Rationale and design for ENHANCE CRT: QLV implant strategy for non-left bundle branch block patients

for the ENHANCE CRT Study Group

Research output: Contribution to journalArticle

Abstract

Aims: Historically, cardiac resynchronization therapy (CRT) response in non-left bundle branch block (non-LBBB) patients has been suboptimal in comparison with that observed in left bundle branch block patients. The electrical activation pattern of the left ventricle (LV) is different between these two QRS morphologies. Small non-randomized studies have suggested that targeting the LV wall with greatest electrical delay may be superior to conventional anatomical pacing from the lateral wall in non-LBBB patients. This article outlines the design and rationale of a prospective, randomized, pilot study, which assesses the effect of a non-traditional LV lead implant strategy on the clinical composite score after 12 months of follow-up in a non-LBBB patient population. Methods: All patients will receive an Abbott quadripolar CRT-D system (Quartet 1458Q LV lead with Unify Quadra™, Quadra Assura™ CRT-D or any market-approved CRT-D device with quadripolar pacing capabilities). Patients will be randomized in a 2:1 ratio between a QLV-based implant strategy vs. standard of care. Up to 250 patients will be enrolled in the study. Conclusions: If the primary endpoint is achieved, this study will provide important information about reducing the non-responder rate in non-LBBB patients and provide further evidence for the QLV-based implant strategy.

Original languageEnglish (US)
JournalESC heart failure
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Cardiac Resynchronization Therapy
Bundle-Branch Block
Heart Ventricles
Cardiac Resynchronization Therapy Devices
Standard of Care

Keywords

  • Cardiac resynchronization therapy
  • Implant strategy
  • Non-LBBB
  • QLV
  • Quartet
  • RBBB

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Rationale and design for ENHANCE CRT : QLV implant strategy for non-left bundle branch block patients. / for the ENHANCE CRT Study Group.

In: ESC heart failure, 01.01.2018.

Research output: Contribution to journalArticle

@article{00037f1ae98341dfb7bd58d1f8d281db,
title = "Rationale and design for ENHANCE CRT: QLV implant strategy for non-left bundle branch block patients",
abstract = "Aims: Historically, cardiac resynchronization therapy (CRT) response in non-left bundle branch block (non-LBBB) patients has been suboptimal in comparison with that observed in left bundle branch block patients. The electrical activation pattern of the left ventricle (LV) is different between these two QRS morphologies. Small non-randomized studies have suggested that targeting the LV wall with greatest electrical delay may be superior to conventional anatomical pacing from the lateral wall in non-LBBB patients. This article outlines the design and rationale of a prospective, randomized, pilot study, which assesses the effect of a non-traditional LV lead implant strategy on the clinical composite score after 12 months of follow-up in a non-LBBB patient population. Methods: All patients will receive an Abbott quadripolar CRT-D system (Quartet 1458Q LV lead with Unify Quadra™, Quadra Assura™ CRT-D or any market-approved CRT-D device with quadripolar pacing capabilities). Patients will be randomized in a 2:1 ratio between a QLV-based implant strategy vs. standard of care. Up to 250 patients will be enrolled in the study. Conclusions: If the primary endpoint is achieved, this study will provide important information about reducing the non-responder rate in non-LBBB patients and provide further evidence for the QLV-based implant strategy.",
keywords = "Cardiac resynchronization therapy, Implant strategy, Non-LBBB, QLV, Quartet, RBBB",
author = "{for the ENHANCE CRT Study Group} and Singh, {Jagmeet P.} and Berger, {Ronald D} and Doshi, {Rahul N.} and Michael Lloyd and Douglas Moore and Daoud, {Emile G.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/ehf2.12340",
language = "English (US)",
journal = "ESC heart failure",
issn = "2055-5822",
publisher = "The Heart Failure Association of the European Society of Cardiology",

}

TY - JOUR

T1 - Rationale and design for ENHANCE CRT

T2 - QLV implant strategy for non-left bundle branch block patients

AU - for the ENHANCE CRT Study Group

AU - Singh, Jagmeet P.

AU - Berger, Ronald D

AU - Doshi, Rahul N.

AU - Lloyd, Michael

AU - Moore, Douglas

AU - Daoud, Emile G.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Aims: Historically, cardiac resynchronization therapy (CRT) response in non-left bundle branch block (non-LBBB) patients has been suboptimal in comparison with that observed in left bundle branch block patients. The electrical activation pattern of the left ventricle (LV) is different between these two QRS morphologies. Small non-randomized studies have suggested that targeting the LV wall with greatest electrical delay may be superior to conventional anatomical pacing from the lateral wall in non-LBBB patients. This article outlines the design and rationale of a prospective, randomized, pilot study, which assesses the effect of a non-traditional LV lead implant strategy on the clinical composite score after 12 months of follow-up in a non-LBBB patient population. Methods: All patients will receive an Abbott quadripolar CRT-D system (Quartet 1458Q LV lead with Unify Quadra™, Quadra Assura™ CRT-D or any market-approved CRT-D device with quadripolar pacing capabilities). Patients will be randomized in a 2:1 ratio between a QLV-based implant strategy vs. standard of care. Up to 250 patients will be enrolled in the study. Conclusions: If the primary endpoint is achieved, this study will provide important information about reducing the non-responder rate in non-LBBB patients and provide further evidence for the QLV-based implant strategy.

AB - Aims: Historically, cardiac resynchronization therapy (CRT) response in non-left bundle branch block (non-LBBB) patients has been suboptimal in comparison with that observed in left bundle branch block patients. The electrical activation pattern of the left ventricle (LV) is different between these two QRS morphologies. Small non-randomized studies have suggested that targeting the LV wall with greatest electrical delay may be superior to conventional anatomical pacing from the lateral wall in non-LBBB patients. This article outlines the design and rationale of a prospective, randomized, pilot study, which assesses the effect of a non-traditional LV lead implant strategy on the clinical composite score after 12 months of follow-up in a non-LBBB patient population. Methods: All patients will receive an Abbott quadripolar CRT-D system (Quartet 1458Q LV lead with Unify Quadra™, Quadra Assura™ CRT-D or any market-approved CRT-D device with quadripolar pacing capabilities). Patients will be randomized in a 2:1 ratio between a QLV-based implant strategy vs. standard of care. Up to 250 patients will be enrolled in the study. Conclusions: If the primary endpoint is achieved, this study will provide important information about reducing the non-responder rate in non-LBBB patients and provide further evidence for the QLV-based implant strategy.

KW - Cardiac resynchronization therapy

KW - Implant strategy

KW - Non-LBBB

KW - QLV

KW - Quartet

KW - RBBB

UR - http://www.scopus.com/inward/record.url?scp=85053882703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053882703&partnerID=8YFLogxK

U2 - 10.1002/ehf2.12340

DO - 10.1002/ehf2.12340

M3 - Article

C2 - 30264456

AN - SCOPUS:85053882703

JO - ESC heart failure

JF - ESC heart failure

SN - 2055-5822

ER -